The role of lympha enectomy in esophageal cancer

Annals of Surgery

Volumn 250, Issue 2, 2009, Pages 206-209

  Jamieson, Glyn G ^a   Lamb, Peter J ^a   Thompson, Sarah K ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELL; CLINICAL EVALUATION; CLINICAL TRIAL; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STANDARDIZATION; SURGICAL MORTALITY; ESOPHAGUS TUMOR; NOMENCLATURE; PATHOLOGY; PATIENT SELECTION;

ESOPHAGEAL NEOPLASMS; HUMANS; LYMPH NODE EXCISION; PATIENT SELECTION; TERMINOLOGY AS TOPIC;

EID: 68949083591     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181b16cd1     Document Type: Review

References (41)

1. Lerut T, De Leyn P, Coosemans W, et al. Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg. 1994;216: 583-590.
2. Altorki N, Kent M, Ferrara C, et al. Three field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg. 2002;236: 177-183.
3. Isono K, Sato H, Nakayama K. Results of a nationwide study on the three-field lymphadenectomy of esophageal cancer. Oncology. 1991;48:411-420.
4. Akiyama H, Tsurumaru M, Udagawa H, et al. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg. 1994;22:364-373. (Pubitemid 24313229)
5. Dresner SM, Griffin SM. Pattern of recurrence following radical oesophagectomy with two field lymphadenectomy. Br J Surg. 2000;87:1426-1433.
6. Skinner DB. En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg. 1983;85:59-67.
7. Hagen JA, Demeester SR, Peters JH, et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg. 2001; 234:520-530.
8. Altorki NK, Skinner DB. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg. 2001;234:581-587.
9. Hulscher JB, VanSandick JW, Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662-1669.
10. Yekebas EF, Schurr PG, Kaifi JT, et al. Effectiveness of radical en bloc esophagectomy compared to transhiatal esophagectomy in squamous cell cancer is influenced by nodal micrometastases. J Surg Oncol. 2006;93:541-549.
11. Li H, Yao SC. Surgical treatment for carcinoma of the esophagus in Chinese language publications. Br J Surg. 1997;84:855-857.
12. Omloo JMT, Lagarde SM, Hulscher JBF, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five year survival of a randomised clinical trial. Ann Surg. 2007;246:992-1001.
13. Peyre CG, Hagen JA, DeMeester SR, et al. Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg. 2008;248:979-985.
14. Nishihira T, Hirayama K, Mori S. A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg. 1998;175:47-51.
15. Fang W, Chen W, Yong J, et al. Thoracoabdominal two field lymphadenectomy combined with adjuvant chemotherapy in the management of thoracic esophageal carcinoma. Chin J Thorac Cardiovasc Surg. 2005;21:268-271.
16. Horstmann O, Verreet PR, Becker H, et al. Transhiatal oesophagectomy compared with transthoracic resection and systematic lymphadenectomy for the treatment of esophageal cancer. Eur J Surg. 1995;161:557-567.
17. Lerut T, Coosemans W, De Leyn P, et al. Reflections on three field lymphadenectomy in carcinoma of the esophagus and gastroesophageal junction. Hepatogastroenterology. 1999;46:717-725.
18. Morgan MA, Lewis WG, Hopper AN, et al. Prospective comparison of transthoracic versus transhiatal esophagectomy following neoadjuvant therapy for esophageal cancer. Dis Esophagus. 2007;20:225-231.
19. Altorki NK, Girardi L, Skinner DB. Enbloc esophagectomy improves survival for stage III esophageal cancer. J Thorac Cardiovasc Surg. 1997;114: 948-955.
20. Kato H, Watanabe N, Tachimori Y, et al. Evaluation of neck dissection for thoracic esophageal carcinoma. Ann Thorac Surg. 1991;51:931-935.
21. Junginger T, Gockel I, Heckhoff S. A comparison of transhiatal and trans-thoracic resections on the prognosis in patients with squamous cell carcinoma of the esophagus. Eur J Surg Oncol. 2006;32:749-755.
22. Altorki NK, Zhou XK, Stiles B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg. 2008;248:221-226.
23. Schwartz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg. 2007;11:1384-1394.
24. Peyre CG, Hagen JA, Demeester SR, et al. The number of involved lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008;248:549-556.
25. Gebski V, Burmeister B, Smithers BM, et al. Australasian Gastrointestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226-234.
26. Lerut T, Nafteux P, Moons J, et al. Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg. 2004;240:962-972.
27. Lagarde SM, Cense HA, Hulscher JBF, et al. Prospective analysis of patients with adenocarcinoma of the gastric cardia and lymph node metastasis in the proximal field of the chest. Br J Surg. 2005;92:1404-1408.
28. O'Sullivan GC, Sheehan D, Clarke A, et al. Micrometastases in esophago-gastric cancer: high detection rate in resected rib segments. Gastroenterology. 1999;116:543-548.
29. Bonavina L, Soligo D, Quirici N, et al. Bone marrow-disseminated tumor cells in patients with carcinoma of the esophagus or cardia. Surgery. 2001; 129:15-22.
30. Thorban S, Rosenberg R, Busch R, et al. Epithelial cells in bone marrow of esophageal cancer patients: a significant prognostic factor in multivariate analysis. Br J Cancer. 2000;83:35-39.
31. Mueller JD, Stein HJ, Oyang T, et al. Frequency and clinical impact of lymph node micrometastasis and tumor cell microinvolvement in patients with adenocarcinoma of the esophagogastric junction. Cancer. 2000;89:1874-1882.
32. Braun S, Vogl FD, Naume B, et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med. 2005;353:793-802. (Pubitemid 41215488)
33. Rice TW, Zuccaro G Jr, Adelstein DJ, et al. Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status. Ann Thorac Surg. 1998;65:787-792.
34. Luketich JD, Kassis ES, Shriver SP, et al. Detection of micrometastases in histologically negative lymph nodes in esophageal cancer. Ann Thorac Surg. 1998;66:1715-1718.
35. Izbicki JR, Hosch SB, Pichlmeier U, et al. Prognostic value of immunohis-tochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med. 1997;337:1188-1194.
36. Jamieson GG, Thompson SK. The detection of lymph node metastases in oesophageal cancer. Br J Surg. 2009;96:21-25.
37. McCulloch P, Ward J, Tekkis PP. ASCOT group of surgeons; British Oesophago-Gastric Cancer Group. Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ. 2003;27:1192-1197.
38. Bartels H, Stein HJ, Siewert JR. Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg. 1998;85:840-844.
39. Puli SR, Reddy JB, Bechtold ML, et al. Staging accuracy of esophageal cancer by endoscopic ultrasound: a meta-analysis and systematic review. World J Gastroenterol. 2008;14:1479-1490.
40. Lamb PJ, Griffin SM, Burt AD, et al. Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma. Br J Surg. 2005; 92:60-67.
41. Kitagawa Y, Fujii H, Mukai M, et al. Sentinel lymph node mapping in esophageal and gastric cancer. Cancer Treat Res. 2005;127:123-139.